GEN Exclusives

More »

GEN News Highlights

More »
May 3, 2007

GPC Consolidates Drug Discovery Activities to Munich Site

  • GPC Biotech is consolidating its drug discovery efforts, and the programs currently being managed in Waltham, MA will be moved to its Munich location. Th company's Waltham facility will be closed and staff will be reduced by approximately 16%. The company is continuing to build its clinical development and commercialization groups based in Princeton, NJ.

    The move comes after the 2005 acquisition of the assets and hiring of many research scientists of Munich-based Axxima Pharmaceuticals, as well as the ending of a collaboration with Altana Pharma in Waltham.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using CRISPRs to Tame GMOs

With more climate-induced droughts and insect infestations on the horizon do you think technologies like CRISPR will change a lot of people’s minds about GMOs, including genetically engineered foods?

More »